GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Rhea-AI Summary

GRAIL, a healthcare company focused on early cancer detection, announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The company's management will present on September 4, 2024, at 3:20 p.m. ET. Investors and interested parties can access both live and replay webcasts of the presentation through GRAIL's investor relations website at investors.grail.com. The webcast will remain available for replay for at least 30 days after the event, providing an opportunity for those unable to attend live to catch up on GRAIL's latest updates and insights.

MENLO PARK, Calif., Aug. 21, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Morgan Stanley 22nd Annual Global Healthcare Conference at 3:20 p.m. ET on Sept. 4, 2024.

Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.

About GRAIL

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-the-morgan-stanley-22nd-annual-global-healthcare-conference-302227805.html

SOURCE GRAIL, Inc.

FAQ

When is GRAIL (GRAL) presenting at the Morgan Stanley Global Healthcare Conference?

GRAIL (GRAL) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024, at 3:20 p.m. ET.

How can investors access GRAIL's (GRAL) presentation at the Morgan Stanley conference?

Investors can access live and replay webcasts of GRAIL's (GRAL) presentation through the investor relations section of GRAIL's website at investors.grail.com.

How long will the webcast of GRAIL's (GRAL) Morgan Stanley conference presentation be available?

The webcast of GRAIL's (GRAL) presentation will be archived and available for replay for at least 30 days after the event.

What is the main focus of GRAIL (GRAL) as a healthcare company?

GRAIL (GRAL) is a healthcare company whose mission is to detect cancer early when it can be cured.